Works matching IS 26662345 AND DT 2025 AND VI 8 AND IP 2

Results: 14
    1
    2
    3
    4
    5

    PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 2, p. 161, doi. 10.36401/JIPO-24-26
    By:
    • Altan, Mehmet;
    • Dawen Sui;
    • Cai Xu;
    • Simon, George R.;
    • Sulihem, Saliha T.;
    • Malveaux, Donna;
    • Ponce, Darcy;
    • Rinsurongkawong, Waree;
    • Rinsurongkawong, Vadeerat;
    • Lee, J. Jack;
    • Jianjun Zhang;
    • Gibbons, Don L.;
    • Vaporciyan, Ara A.;
    • Heymach, John V.;
    • Santorelli, Melissa L.;
    • Burke, Thomas;
    • Williams, Loretta A.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 2, p. 89, doi. 10.36401/JIPO-24-17
    By:
    • Nardo, Mirella;
    • Gouda, Mohamed A.;
    • Reilley, Matthew J.;
    • Biter, Amadeo B.;
    • Lim, Joann;
    • Bean, Stacie A.;
    • Nguyen, Ly M.;
    • Bhosale, Priya R.;
    • Ager, Casey R.;
    • Couillault, Coline A.;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Tsimberidou, Apostolia M.;
    • Yap, Timothy A.;
    • Aung Naing;
    • Rodon, Jordi;
    • Subbiah, Vivek;
    • Karp, Daniel D.;
    • Curran, Michael A.;
    • Hong, David S.
    Publication type:
    Article
    14